HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

American Journal of Human Genetics

Volumn 72, Issue 3, 2003, Pages 710-716

  Barcellos, L F ^a   Oksenberg, J R ^a   Begovich, A B ^c   Martin, E R ^d   Schmidt, S ^d   Vittinghoff, E ^b   Goodin, D S ^a   Pelletier, D ^a   Lincoln, R R ^a   Bucher, P ^a   Swerdlin, A ^a   Pericak Vance, M A ^d   Haines, J L ^e   Hauser, S L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA DR2 ANTIGEN;

ADULT; ALLELE; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; HAPLOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MALE; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; RISK FACTOR;

EID: 0037371325     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/367781     Document Type: Article

References (45)

1. Allegretta M, Nicklas JA, Sriram S, Albertini RJ (1990) T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718-721
2. Barcellos LF, Oksenberg JR, Green AJ, Bucher P, Rimmler JB, Schmidt S, Garcia ME, Lincoln RR, Pericak-Vance MA, Haines JL, Hauser SL (2002) Genetic basis for clinical expression in multiple sclerosis. Brain 125:150-158
3. Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R, Callier S, Elkins MK, Goodkin DE, Haines JL, Pericak-Vance MA, Hauser SL, Oksenberg JR (2000) CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group. Immunogenetics 51:281-288
4. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78:318-323
5. Bertrams J, Kuwert E (1972) HL-A antigen frequencies in multiple sclerosis: significant increase of HL-A3, HL-A10 and WS, and decrease of HL-A12. Eur Neurol 7:74-78
6. Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A (1998) The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain 121:1869-1887
7. Doolittle TH, Myers RH, Lehrich JR, Birnbaum G, Sheremata W, Franklin GM, Nelson LM, Hauser SL (1990) Multiple sclerosis sibling pairs: clustered onset and familial predisposition. Neurology 40:1546-1552
8. El-Gabalawy HS, Goldbach-Mansky R, Smith D II, Arayssi T, Bale S, Gulko P, Yarboro C, Wilder RL, Klippel JH, Schumacher HR Jr (1999) Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 42:1696-1705
9. Garcia-Merino A, Alper CA, Usuku K, Marcus-Bagley D, Lincoln R, Awdeh Z, Yunis EJ, Eisenbarth GS, Brink SJ, Hauser SL (1996) Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum Immunol 50:11-21
10. Goodkin DE, Doolittle TH, Hauser SL, Ransohoff RM, Roses AD, Rudick RA (1991) Diagnostic criteria for MS research involving multiply affected families. Archives of Neurology 48:805-807
11. Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205-1213
12. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, et al (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat Genet 13:469-471
13. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, Gatto N, Goodkin DE, Hauser SL (1998) Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum Mol Genet 7:1229-1234
14. Kantarci OH, de Andrade M, Weinshenker BG (2002) Identifying disease modifying genes in multiple sclerosis. J Neuroimmunol 123:144-159
15. Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y, Hasuo K, Tobimatsu S, Kobayashi T (1996) Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40:569-574
16. Kurtzke JF (1983) Rating neurologic impairment in MS: an expanded disability status scale. Neurology 33:1444-1452
17. Liang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13-22
18. Ligers A, Dyment DA, Willer CJ, Sadovnick AD, Ebers G, Risch N, Hillert J and the Canadian Collaborative Study Groups (2001) Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am J Hum Genet 69:900-903
19. Marrosu MG, Cocco E, Lai M, Spinicci G, Pischedda MP, Contu P (2002) Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study. Lancet 359:1461-1465
20. Martin ER, Bass MP, Kaplan NL (2001) Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 68:1065-1067
21. Martin ER, Monks SA, Warren LL, Kaplan NL (2000) A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 67:146-154
22. Martin R, Jaraquemada D, Flerlage M, Richert J, Whitaker J, Long EO, McFarlin DE, McFarland HF (1990) Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 145:540-548
23. McWeeney S, Thomson G (2000) Meta analysis of relative penetrance rank order statistics with application to HLA DR-DQ genes and type 1 diabetes. A J Hum Genet 67:A214
24. MSG Group (1998) Clinical demographics of multiplex families with multiple sclerosis. Annals of Neurology 43:530-534
25. Naito S, Namerow N, Mickey MR, Terasaki PI (1972) Multiple sclerosis: association with HL-A3. Tissue Antigens 2:1-4
26. O'Connell JR, Weeks DE (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266
27. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherrit M, Rothbard J, Bernard CCA, Steinman L (1993) Selection for T-cell receptor V β-D β-J β gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68-70
28. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187
29. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M, Ruddle NH, Steinman L (1990) Lymphotoxin and tumor necrosis factor-α production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol 2:539-544
30. Rasmussen HB, Kelly MA, Clausen J (2001) Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis. Mult Scler 7:91-93
31. Rubio JP, Bahlo M, Butzkueven H, van der Mei IA, Sale MM, Dickinson JL, Groom P, Johnson LJ, Simmons RD, Tait B, Varney M, Taylor B, Dwyer T, Williamson R, Gough NM, Kilpatrick TJ, Speed TP, Foote SJ (2002) Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis. Am J Hum Genet 70:1125-1137
32. Scholz C, Patton KT, Anderson DE, Freeman GJ, Hafler DA (1998) Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol 160:1532-1538
33. Smith KJ, Pyrdol J, Gauthier L, Wiley DC, Wucherpfennig KW (1998) Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med 188:1511-1520
34. Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982: a survey. Immunol Rev 70:193-218
35. Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ (2001) Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol 31:907-917
36. Thomson G (1995) Mapping disease genes: family-based association studies. Am J Hum Genet 57:487-498
37. Todd JA, Bell JI, McDevitt HO (1987) HLA-DQ β gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604
38. Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L (1993) Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 91:616-628
39. van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schreuder GM, de Vries RR, Zanelli E (1999) HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 60:152-158
40. Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB, Rodriguez M (1998) Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 51:742-747
41. Weyand CM, Xie C, Goronzy JJ (1992) Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 89:2033-2039
42. Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL (1995) Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 92:11935-11939
43. Zanelli E, Breedveld FC, de Vries RR (2000) HLA association with autoimmune disease: a failure to protect? Rheumatology 39:1060-1066
44. Zeger SL, Liang KY (1992) An overview of methods for the analysis of longitudinal data. Stat Med 11:1825-1839
45. Zipp F, Weber F, Huber S, Sotgiu S, Czlonkowska A, Holler E, Albert E, Weiss EH, Wekerle H, Hohlfeld R (1995) Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-α by HLA-DR2+ T cells. Ann Neurol 38:723-730